Duration and intensity of fluconazole for prophylaxis in preterm neonates: a meta-analysis of randomized controlled

Datian Che1, Hua Zhou2, Te Li3

  • 1Department of Respiratory Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.

Abstract

Insights

Fluconazole prophylaxis effectively prevents invasive fungal infections in preterm infants in neonatal intensive care units (NICUs). A 42-day treatment duration is superior to shorter courses or no prophylaxis, though mortality rates remain unaffected.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Invasive fungal infections (IFIs) pose a significant risk to preterm neonates in NICUs.
  • Fluconazole is recognized as an effective prophylactic agent against IFIs in this vulnerable population.
  • Optimal duration and dosing strategies for fluconazole prophylaxis remain debated, necessitating further investigation.

Purpose of the Study:

  • To systematically review and meta-analyze the efficacy of fluconazole prophylaxis in preventing IFIs in preterm neonates.
  • To compare different durations of fluconazole prophylaxis.
  • To assess the impact of fluconazole prophylaxis on mortality in preterm neonates.

Main Methods:

  • A comprehensive search of PubMed and EMBASE was conducted without restrictions.
  • Five randomized controlled trials (RCTs) involving 1006 preterm neonates were included in the meta-analysis.
  • Fixed- and random-effects models were used to calculate pooled relative risks (RRs), with meta-regression exploring heterogeneity.

Main Results:

  • A 42-day duration of prophylactic fluconazole significantly reduced the risk of IFIs (RR 0.30, p=0.0004) compared to no prophylaxis.
  • A 28-day duration showed no significant difference in IFI risk (RR 0.80, p=0.4048).
  • Fluconazole dosage did not significantly impact IFI risk, and no significant difference in mortality was observed between groups (RR 0.82, p=0.2093).

Conclusions:

  • Prophylactic fluconazole for 42 days is a superior strategy for preventing IFIs in preterm infants in NICUs, excluding mortality benefits.
  • The dosing regimen may not influence outcomes, but further research is recommended due to data limitations.

Related Concept Videos